Skip to main content
Clinical Trials/NCT02841397
NCT02841397
Completed
N/A

Validation of a Pulse Oximetry Based Hemoglobin Measurement System. Comparison of Plethysmographic Variability Index to Standard Methods of Guiding Fluid and Transfusion Management in the Critically Ill Adult Patients. Validation of Clinical Efficacy of ORI for Supplemental Oxygen Titration

Masimo Corporation1 site in 1 country50 target enrollmentMarch 9, 2017
ConditionsSurgery

Overview

Phase
N/A
Intervention
Not specified
Conditions
Surgery
Sponsor
Masimo Corporation
Enrollment
50
Locations
1
Primary Endpoint
Correlation of "ORI" With Partial Pressure of Oxygen (PaO2) "PaO2" Measurement From Blood Gas Analysis
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study goal is to establish the correlation of hemoglobin values determined by the noninvasive pulse oximetry-determined hemoglobin (SpHb) system with hemoglobin as measured by other validated devices. The study will also evaluation oxygen reserve index (ORI) to correlate with partial pressure of oxygen (PaO2), and to evaluate pleth variability index (PVI) with stroke volume variation (SVV) or pulse pressure variation (PPV) values.

Registry
clinicaltrials.gov
Start Date
March 9, 2017
End Date
October 11, 2017
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Admitted into the ICU
  • Aged 18 years or older
  • Mechanically ventilated
  • Arterial line placed
  • Vigileo/Flotrac System being used for guidance of fluid management

Exclusion Criteria

  • Pregnancy
  • Prisoner status
  • Extreme hemodynamic instability
  • Multiple vasopressors in use with questionable peripheral blood flow
  • Lack of appropriate sites for sensor placement
  • Patient or patient's legal representative refusal

Outcomes

Primary Outcomes

Correlation of "ORI" With Partial Pressure of Oxygen (PaO2) "PaO2" Measurement From Blood Gas Analysis

Time Frame: Duration of study participation is up to three days.

Concordance will be determined by comparing the trending ability of the Oxygen Reserve Index (ORI) measurement of the sensor with that of Partial Pressure of Oxygen in Blood (PaO2).

Noninvasive Pulse Oximetry-determined SpHb Bias

Time Frame: Duration of study participation is up to three days.

Accuracy of SpHb will be determined by comparing it to the hemoglobin value obtained from a reference blood sample and calculating the accuracy root mean square (Arms) error value. In order to obtain the Arms value, the blood sample hemoglobin value is subtracted from SpHb value for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.

Correlation of PVI Measurement Compared With PPV or SVV

Time Frame: Duration of study participation is up to three days.

Correlation of PVI measurement compared with pulse pressure variation PPV or stroke volume variation (SVV) measurement from arterial catheter

Study Sites (1)

Loading locations...

Similar Trials